Thyrocare Technologies Ltd (BOM:539871)

Q1 2027 Thyrocare Technologies Ltd Earnings Call Transcript

Jul 23, 2026 / 12:30 PM GMT

Release Date Price: ₹545.55 (-2.30%)

Transcript

Key Points

Positve

Thyrocare Technologies Ltd (BOM:539871) reported a strong revenue growth of 24% year-on-year in Q1 FY27, driven primarily by its core pathology business.
The company's franchisee network has expanded significantly, reaching 11,700 active franchisees, a four-fold increase since FY '21.
Thyrocare Technologies Ltd (BOM:539871) has been recognized with multiple awards, including India's Most Trusted Customer-Focused Diagnostic Brand 2026 and Diagnostic Chain of the Year.
The company has successfully expanded its laboratory network from 17 labs in FY '21 to 44 labs, enhancing its geographical reach and operational capabilities.
Thyrocare Technologies Ltd (BOM:539871) is making strategic investments in specialty diagnostics, aiming to capture a larger market share in this under-penetrated segment.

Negative

The company's pathology business excluding COVID experienced a significant decline in FY '21, with a 20% decrease in revenue compared to the previous year.
Thyrocare Technologies Ltd (BOM:539871) faces challenges in its nuclear business, which has not been growing and is under consideration for divestment.
The specialty diagnostics segment is still in its nascent stage, and the company has not provided specific guidance on its future contribution to revenue.
There is a potential risk of franchisee churn, which could impact the company's growth projections and network expansion plans.
The company's radiology business reported a year-on-year revenue decline of 4%, primarily due to the consolidation of centers.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

THYO.NS - Thyrocare Technologies Ltd
Q1 2027 Thyrocare Technologies Ltd Earnings Call
Jul 23, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the ThyroCare Q1 FY27 Earning Conference Call hosted by ThyroCare Technologies Limited.

As a reminder, all participant line will be in the listen-only mode and there will be an opportunity for you to ask question after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing star, then zero on your touchtone phone.

I now hand the conference over to Mr. Preet Joshi from Thyrocare.

Thank you and over to you, Preet.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.